NFKB1 and myeloid sarcoma: As for ASTs in MS, although their beneficial or detrimental role is still controversial, it is worth noting that it has been shown that activated ASTs produce HB-EGF [257], which in turn blocks NF-kB activation in intestinal epithelial cells [258].